Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Microchip Technology Appoints Mitch Little to Its Board of Directors
-
LXP Industrial Trust Provides Recent Business Activity Update and Increases 2026 Adjusted Company FFO Guidance
-
Global Self Storage Declares Second Quarter 2026 Dividend
-
JM Group Limited Provides Further Update Regarding Trading Halt of its Securities
-
Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026
-
UroGen Pharma to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
-
REPAY Completes Acquisition of KUBRA
-
Kodiak Copper Announces C$10 Million Financing
-
Utah Communities Rally Around 22-Year-Old Heart Transplant Recipient
-
Digital Commerce Group (DCGroup) Announces $100K Fintech Grant in Partnership with Startupfest
-
HPE Names Chris Hsu to Board of Directors
-
/C O R R E C T I O N -- Schlesinger Law Offices, P.A./
-
HPE Reports Fiscal 2026 Second Quarter Results
-
Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
-
Array completes sale of select spectrum assets to Verizon for $1.0 billion
-
John Daly Bets on the Future of Golf: Takes Equity Stake in Skill Shot Golf to Bring Real-Money Contests to Every Course in America
-
Dave & Buster’s Entertainment, Inc. to Report First Quarter 2026 Financial Results on June 15, 2026
-
WF International Limited Announces Share Consolidation
-
ROLLINS TO PRESENT AT UPCOMING INVESTOR CONFERENCES
-
Credo Technology Group Holding Ltd Reports Fourth Quarter and Fiscal Year 2026 Financial Results
-
Cirius Therapeutics Announces Presentation on CIR-0602K as Novel Diabetes Treatment at the American Diabetes Association's 2026 Scientific Sessions
-
Zeta Global Announces Olympic Gold Medalist, Entrepreneur and Founder Lindsey Vonn as Second Zeta Live 2026 Keynote Speaker
-
New Jersey Natural Gas Submits Filings to NJBPU for Customer Savings and Future Recovery of Reliability Investments
-
AAR announces participation in 2026 William Blair Growth Stock Conference
-
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Penguin Solutions Announces CFO Transition
-
Sonos Announces Participation in Rosenblatt’s 6th Annual Technology Virtual Summit
-
Amtech Systems Announces Proposed Public Offering of Common Stock
-
Broadcom Connects the AI Edge with Comprehensive Multi-Gig Broadband and Wi-Fi 8 Innovations
-
HONEYWELL APPOINTS JILL EVANKO TO BOARD OF DIRECTORS
-
DHI Group to Present at the Noble Capital Markets Emerging Growth Virtual Equity Conference on June 4, 2026
-
Agilysys to Participate in the William Blair 46th Annual Growth Stock Conference
-
8x8, Inc. Announces Participation in Evercore Global TMT Conference
-
Eaton Vance Limited Duration Income Fund, Eaton Vance Senior Floating-Rate Trust, and Eaton Vance Senior Income Trust Announce Final Results of Auction Preferred Shares Tender Offers
-
Forgent Power Solutions Announces Closing of Public Offering of Class A Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Powerfleet Sets Fourth Quarter Fiscal 2026 Conference Call for Monday, June 15, 2026, at 8:30 a.m. ET
-
Central Securities Corporation Declares Dividend
-
Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis
-
Tredegar Announces Bonnell Aluminum Leadership Changes
-
Curbline Properties Second Quarter 2026 Investment and Capital Markets Update
-
BGC Group to Present at the Piper Sandler Global Exchange & FinTech Conference on June 4, 2026
-
SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION
-
Contineum Therapeutics to Present at the 2026 Goldman Sachs Global Healthcare Conference
-
Heidmar Maritime Holdings Corp. Announces Transition in Chief Financial Officer Role
-
Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review
-
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Epsilon Energy LTD. Announces Quarterly Dividend and Borrowing Base Redetermination
-
Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
